Dopaminergic agonists in the treatment of Parkinson's disease.
Goetz
C G
CG
Department of Neurological Sciences, Rush Presbyterian-St. Luke's Medical Center, Chicago, IL 60612.
D001971:Bromocriptine / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use; D015259:Dopamine Agents / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D010479:Pergolide / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use
D015259:Dopamine Agents; D010479:Pergolide; D001971:Bromocriptine